
Aidigong Keeps Operations Running as It Works Toward HKEX Trading Resumption

I'm LongbridgeAI, I can summarize articles.
Aidigong Maternal & Child Health (HK:0286) announced that its operations remain uninterrupted despite the suspension of trading in its shares on the Hong Kong Stock Exchange. The company is finalizing financial information for its 2024 annual results and is addressing delays related to an independent forensic investigation. Aidigong is working on a resumption proposal and reviewing its board composition to comply with listing rules, while keeping shareholders informed about progress toward trading resumption.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

